Case Report
Published on 01 Apr 2025
Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1543622
- 216 views
Type at least 3 characters
1,400 articles
Mini Review
Accepted on 31 Mar 2025
Cell-Based Immunotherapies for Solid Tumors: Advances, Challenges, and Future Directions
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1551583
Review
Accepted on 31 Mar 2025
Expanding horizons of cancer immunotherapy: hopes and hurdles
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1511560
Review
Accepted on 31 Mar 2025
Rewiring Lipid Metabolism to Enhance Immunotherapy Efficacy in Melanoma: A Frontier in Cancer Treatment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1519592
Review
Accepted on 28 Mar 2025
Nanoparticle-Mediated Delivery of Herbal-Derived Natural Products to Modulate Immunosenescence-Induced Drug Resistance in Cancer Therapy: A Comprehensive Review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1567896
Case Report
Accepted on 27 Mar 2025
A rare case of sintilimab-induced dermatomyositis in a patient with gastric cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1517391
Editorial
Published on 27 Mar 2025
Editorial: Immunotherapy: up to date progress in childhood and hematological malignancies
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1584101
- 210 views
Mini Review
Accepted on 26 Mar 2025
Single-Cell RNA Sequencing in Diffuse Large B-Cell Lymphoma: Tumor Heterogeneity, Microenvironment, Resistance, and Prognostic Markers
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1583250
Original Research
Published on 26 Mar 2025
Integrating multi-omics and machine learning methods reveals the metabolism of amino acids and derivatives-related signature in colorectal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1565090
- 270 views
Mini Review
Accepted on 25 Mar 2025
Activation-Induced Cytidine Deaminase in Tertiary Lymphoid Structures: Dual Roles and Implications in Cancer Prognosis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1555491
Original Research
Published on 25 Mar 2025
Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1560625
- 297 views
Editorial
Accepted on 24 Mar 2025
Editorial: Mitochondria in the regulation of anti-tumor immunity
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1596146
Case Report
Published on 24 Mar 2025
Promising outcomes of the PD-L1 inhibitor Socazolimab in recurrent and metastatic cervical cancer: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1541760
- 386 views
Original Research
Published on 21 Mar 2025
Tumor–lymph cross-plane projection reveals spatial relationship features: a ResNet-CBAM model for prognostic prediction in esophageal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1567238
- 210 views
Case Report
Published on 21 Mar 2025
A case of camrelizumab-induced anaphylaxis and successful rechallenge: a case report and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1537205
- 204 views
Mini Review
Accepted on 20 Mar 2025
Bispecific Antibodies in Immunotherapy for Acute Leukemia: Latest Updates from the 66th Annual Meeting of the American Society of Hematology, 2024
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1566202